Zimmer Biomet (ZBH) — insider trading
Health Care · NYSE
Zimmer Biomet (ZBH) has 59 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 59 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Campbell Gary Craig | Officer (President, Americas) | Option exercise / conversion (derivative) | 1,218 | — | $0 | Form 4 |
| 2026-10-01 | Campbell Gary Craig | Officer (President, Americas) | Option exercise / conversion (derivative) | 2,368 | — | $0 | Form 4 |
| 2026-10-01 | Campbell Gary Craig | Officer (President, Americas) | Shares withheld for taxes / exercise cost | 480 | $88.42 | $42.4K | Form 4 |
| 2026-10-01 | Campbell Gary Craig | Officer (President, Americas) | Option exercise / conversion | 1,218 | — | $0 | Form 4 |
| 2026-10-01 | Campbell Gary Craig | Officer (President, Americas) | Shares withheld for taxes / exercise cost | 932 | $88.42 | $82.4K | Form 4 |
| 2026-10-01 | Campbell Gary Craig | Officer (President, Americas) | Option exercise / conversion | 2,368 | — | $0 | Form 4 |
| 2026-09-30 | Kolli Sreelakshmi | Director | Grant / award / vesting (derivative) | 174 | — | $0 | Form 4 |
| 2026-09-30 | Kurdikar Devdatt | Director | Grant / award / vesting (derivative) | 174 | — | $0 | Form 4 |
| 2026-09-30 | Hilado Maria Teresa | Director | Grant / award / vesting (derivative) | 376 | — | $0 | Form 4 |
| 2026-09-30 | Shapiro Louis | Director | Grant / award / vesting (derivative) | 153 | — | $0 | Form 4 |
| 2026-09-30 | HIGGINS ARTHUR J | Director | Grant / award / vesting (derivative) | 306 | — | $0 | Form 4 |
| 2026-09-30 | HAGEMANN ROBERT | Director | Grant / award / vesting (derivative) | 306 | — | $0 | Form 4 |
| 2026-09-30 | Farrell Michael J. | Director | Grant / award / vesting (derivative) | 417 | — | $0 | Form 4 |
| 2026-09-11 | Thornal Kevin R | Officer (Grp Pres-Global Business) | Open-market sale | 5,691 | $92.95 | $529.0K | Form 4 |
| 2026-09-04 | Phipps Chad F | Officer (See remarks below.) | Open-market sale | 3,000 | $98.35 | $295.1K | Form 4 |
| 2026-08-03 | Desai Chintan | Officer (President, APAC) | Grant / award / vesting (derivative) | 10,168 | — | $0 | Form 4 |
| 2026-08-01 | Thornal Kevin R | Officer (Grp Pres-Global Business) | Option exercise / conversion (derivative) | 9,957 | — | $0 | Form 4 |
| 2026-08-01 | Thornal Kevin R | Officer (Grp Pres-Global Business) | Shares withheld for taxes / exercise cost | 4,266 | $92.68 | $395.4K | Form 4 |
| 2026-08-01 | Thornal Kevin R | Officer (Grp Pres-Global Business) | Option exercise / conversion | 9,957 | — | $0 | Form 4 |
| 2026-06-30 | Shapiro Louis | Director | Grant / award / vesting (derivative) | 159 | — | $0 | Form 4 |
| 2026-06-30 | Farrell Michael J. | Director | Grant / award / vesting (derivative) | 433 | — | $0 | Form 4 |
| 2026-06-30 | Kolli Sreelakshmi | Director | Grant / award / vesting (derivative) | 180 | — | $0 | Form 4 |
| 2026-06-30 | HIGGINS ARTHUR J | Director | Grant / award / vesting (derivative) | 317 | — | $0 | Form 4 |
| 2026-06-30 | HAGEMANN ROBERT | Director | Grant / award / vesting (derivative) | 317 | — | $0 | Form 4 |
| 2026-06-30 | Kurdikar Devdatt | Director | Grant / award / vesting (derivative) | 180 | — | $0 | Form 4 |
| 2026-06-30 | Hilado Maria Teresa | Director | Grant / award / vesting (derivative) | 389 | — | $0 | Form 4 |
| 2026-06-01 | Noor Jehanzeb | Officer (See remarks below.) | Grant / award / vesting (derivative) | 1,857 | — | $0 | Form 4 |
| 2026-05-29 | Yi Sang | Officer (Group President, Asia Pacific) | Open-market sale | 800 | $82.66 | $66.1K | Form 4 |
| 2026-05-29 | Yi Sang | Officer (Group President, Asia Pacific) | Open-market sale | 4,200 | $82.64 | $347.1K | Form 4 |
| 2026-05-22 | HAGEMANN ROBERT | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | HAGEMANN ROBERT | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | HIGGINS ARTHUR J | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | HIGGINS ARTHUR J | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | Jafry Syed A. | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | Jafry Syed A. | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | Kolli Sreelakshmi | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | Kolli Sreelakshmi | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | Kurdikar Devdatt | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | Kurdikar Devdatt | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | Shapiro Louis | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | Shapiro Louis | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | Hilado Maria Teresa | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | Hilado Maria Teresa | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | BERNARD BETSY J | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | BERNARD BETSY J | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-22 | Farrell Michael J. | Director | Grant / award / vesting (derivative) | 1,517 | — | $0 | Form 4 |
| 2026-05-22 | Farrell Michael J. | Director | Grant / award / vesting (derivative) | 875 | — | $0 | Form 4 |
| 2026-05-01 | Stellato Paul A | Officer (VP, Controller, CAO) | Grant / award / vesting (derivative) | 9,232 | — | $0 | Form 4 |
| 2026-04-01 | Noor Jehanzeb | Officer (See remarks below.) | Option exercise / conversion (derivative) | 6,626 | — | $0 | Form 4 |
| 2026-04-01 | Noor Jehanzeb | Officer (See remarks below.) | Shares withheld for taxes / exercise cost | 1,677 | $90.67 | $152.1K | Form 4 |
| 2026-04-01 | Noor Jehanzeb | Officer (See remarks below.) | Option exercise / conversion | 6,626 | — | $0 | Form 4 |
| 2026-03-31 | Farrell Michael J. | Director | Grant / award / vesting (derivative) | 421 | — | $0 | Form 4 |
| 2026-03-31 | HAGEMANN ROBERT | Director | Grant / award / vesting (derivative) | 309 | — | $0 | Form 4 |
| 2026-03-31 | Kurdikar Devdatt | Director | Grant / award / vesting (derivative) | 154 | — | $0 | Form 4 |
| 2026-03-31 | HIGGINS ARTHUR J | Director | Grant / award / vesting (derivative) | 309 | — | $0 | Form 4 |
| 2026-03-31 | Hilado Maria Teresa | Director | Grant / award / vesting (derivative) | 379 | — | $0 | Form 4 |
| 2026-03-31 | Shapiro Louis | Director | Grant / award / vesting (derivative) | 154 | — | $0 | Form 4 |
| 2026-03-31 | Kolli Sreelakshmi | Director | Grant / award / vesting (derivative) | 175 | — | $0 | Form 4 |
| 2026-03-31 | Jafry Syed A. | Director | Grant / award / vesting (derivative) | 182 | — | $0 | Form 4 |
Ask the chat about ZBH's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Zimmer Biomet (ZBH).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.